Kinet seeks to unlock Smiths Group potential
This article was originally published in Clinica
Executive Summary
Lawrence Kinet, incoming medical division managing director at London, UK-based Smiths Group, has unveiled a new company strategy, which he says will "unlock the potential in a $170 billion medical device industry that continues to undergo change". The £420 million ($600 million) company will restructure into nine global business units (GBUs), assigned to therapy areas.